Larimar Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5171251003
USD
3.07
-0.38 (-11.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryLarimar Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-11.01%
-0.51%
1W
-16.58%
-1.37%
1M
-11.53%
0.35%
YTD
-19.42%
0.54%
1Y
-16.35%
13.99%
3Y
-42.51%
66.39%
5Y
-83.77%
77.77%
10Y
-83.77%
259.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-19.21%
0%
-19.21%
6 Months
-7.25%
0%
-7.25%
1 Year
-16.35%
0%
-16.35%
2 Years
-50.08%
0%
-50.08%
3 Years
-42.51%
0%
-42.51%
4 Years
-64.91%
0%
-64.91%
5 Years
-83.77%
0%
-83.77%

Larimar Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary